Clinical trial
Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects
NCT00158873 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00158873 |
|---|---|
| Title | Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects |
| Official title | A Centre-Randomized, Open-Label, Cross-Over Study to Compare the Pharmaco-Economic Consequences of an Ultiva (Remifentanil Hydrochloride) Based Regimen With Conventional Sedative Based Regimens in ICU Subjects Requiring Short-Term Mechanical Ventilation With Analgesia and Sedation |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sedation |
| Intervention type | Drug |
| Interventions | midazolam, lorazepam, fentanyl, morphine, remifentanil, propofol |
| Enrollment | 224 |
| Start date | Sep 1, 2004 |
| First posted | Sep 12, 2005 |
| Last update posted | Oct 16, 2008 |
| Countries | Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: